Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7647)
All Articles published online
|
Publishing Process of This Article
|
Apr 21, 2018 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lai Q, Melandro F, Larghi Laureiro Z, Giovanardi F, Ginanni Corradini S, Ferri F, Hassan R, Rossi M, Mennini G. Platelet-to-lymphocyte ratio in the setting of liver transplantation for hepatocellular cancer: A systematic review and meta-analysis. World J Gastroenterol 2018; 24(15): 1658-1665 [PMID: 29686473 DOI: 10.3748/wjg.v24.i15.1658] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v24/i15/1658.htm |
| Number | Citing Articles |
| 1 |
Quirino Lai, Samuele lesari, Jan P. Lerut. The impact of biological features for a better prediction of posttransplant hepatocellular cancer recurrence. Current Opinion in Organ Transplantation 2022; 27(4): 305 doi: 10.1097/MOT.0000000000000955
|
| 2 |
José Sánchez Segura, Francisco Javier León Díaz, María Pérez Reyes, Daniel Cabañó Muñoz, Belinda Sánchez Pérez, Jose Antonio Pérez Daga, Custodia Montiel Casado, Julio Santoyo Santoyo. Predictive Models of Hepatocellular Carcinoma Recurrence After Liver Transplantation. Transplantation Proceedings 2020; 52(2): 546 doi: 10.1016/j.transproceed.2019.11.048
|
| 3 |
Songping Cui, Shuang Cao, Qing Chen, Qiang He, Ren Lang. Preoperative systemic inflammatory response index predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1118053
|
| 4 |
Media N. Ismael, Justin Forde, Eduardo Milla, Walid Khan, Roniel Cabrera. Utility of Inflammatory Markers in Predicting Hepatocellular Carcinoma Survival after Liver Transplantation. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/7284040
|
| 5 |
Agata Michalak, Halina Cichoż-Lach, Małgorzata Guz, Joanna Kozicka, Marek Cybulski, Witold Jeleniewicz, Andrzej Stepulak. Towards an evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients with hematological scales. World Journal of Gastroenterology 2020; 26(47): 7538-7549 doi: 10.3748/wjg.v26.i47.7538
|
| 6 |
Chloé Paul, Camille Besch, Thierry Artzner, Baptiste Michard, Caterina Cusumano, Pietro Addeo, Philippe Bachellier, François Faitot. Additional value of interleukin-6 level to predict histopathological features of hepatocellular carcinoma before liver transplantation. Cytokine 2023; 169: 156286 doi: 10.1016/j.cyto.2023.156286
|
| 7 |
Riccardo Pravisani, Federico Mocchegiani, Miriam Isola, Dario Lorenzin, Gian Luigi Adani, Vittorio Cherchi, Maria De Martino, Andrea Risaliti, Quirino Lai, Marco Vivarelli, Umberto Baccarani. Postoperative Trends and Prognostic Values of Inflammatory and Nutritional Biomarkers after Liver Transplantation for Hepatocellular Carcinoma. Cancers 2021; 13(3): 513 doi: 10.3390/cancers13030513
|
| 8 |
Weronika Domerecka, Anna Kowalska-Kępczyńska, Iwona Homa-Mlak, Agata Michalak, Radosław Mlak, Marcin Mazurek, Halina Cichoż-Lach, Teresa Małecka-Massalska. The Usefulness of Extended Inflammation Parameters and Systemic Inflammatory Response Markers in the Diagnostics of Autoimmune Hepatitis. Cells 2022; 11(16): 2554 doi: 10.3390/cells11162554
|
| 9 |
Walaa Abdelhamed, Mohamed El-Kassas. Hepatocellular carcinoma recurrence: Predictors and management. Liver Research 2023; 7(4): 321 doi: 10.1016/j.livres.2023.11.004
|
| 10 |
Lixing Liu, Yang Gong, Qinglin Zhang, Panpan Cai, Li Feng. Prognostic Roles of Blood Inflammatory Markers in Hepatocellular Carcinoma Patients Taking Sorafenib. A Systematic Review and Meta-Analysis. Frontiers in Oncology 2020; 9 doi: 10.3389/fonc.2019.01557
|
| 11 |
Juan Zheng, Hua Wang. Association Between Platelet-to-Lymphocyte Ratio and Preterm Necrotizing Enterocolitis. Frontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.686880
|
| 12 |
Hugo Pinto Marques, Sílvia Gomes da Silva, Eleonora De Martin, Vatche G. Agopian, Paulo N. Martins. Emerging biomarkers in HCC patients: Current status. International Journal of Surgery 2020; 82: 70 doi: 10.1016/j.ijsu.2020.04.043
|
| 13 |
Dominik Šafčák, Sylvia Dražilová, Jakub Gazda, Igor Andrašina, Svetlana Adamcová-Selčanová, Radovan Barila, Michal Mego, Marek Rác, Ľubomír Skladaný, Miroslav Žigrai, Martin Janičko, Peter Jarčuška. Alcoholic Liver Disease-Related Hepatocellular Carcinoma: Characteristics and Comparison to General Slovak Hepatocellular Cancer Population. Current Oncology 2023; 30(3): 3557 doi: 10.3390/curroncol30030271
|
| 14 |
Ajacio Bandeira de Mello Brandão, Santiago Rodriguez, Cláudio Augusto Marroni, Alfeu de Medeiros Fleck Junior, Matheus V. Fernandes, Marcos Mucenic. Performance of eight predictive models for hepatocellular carcinoma recurrence after liver transplantation: A comparative study. Annals of Hepatology 2024; 29(2): 101184 doi: 10.1016/j.aohep.2023.101184
|
| 15 |
Quirino Lai, Nicoletta De Matthaeis, Michele Finotti, Giovanni Galati, Giuseppe Marrone, Fabio Melandro, Filomena Morisco, Daniele Nicolini, Riccardo Pravisani, Edoardo G. Giannini. The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma. European Journal of Clinical Investigation 2023; 53(1) doi: 10.1111/eci.13870
|
| 16 |
Fabio Melandro, Davide Ghinolfi, Quirino Lai. Perfusate Enzymes and Platelets Indicate Early Allograft Dysfunction After Transplantation of Normothermically Preserved Livers. Transplantation 2022; 106(11): e499 doi: 10.1097/TP.0000000000004309
|
| 17 |
Rong-Yun Mai, Ting-Li Lu, Ri-Jin Lu, Can Zeng, Fang Lian, Le-Qun Li, Guo-Bin Wu, Jia-Zhou Ye. C-Reactive Protein-Albumin Ratio (CAR): A More Promising Inflammation-Based Prognostic Marker for Patients Undergoing Curative Hepatectomy for Hepatocellular Carcinoma. Journal of Inflammation Research 2024; : 919 doi: 10.2147/JIR.S441623
|
| 18 |
Maria J Citores, Jose L Lucena, Sara de la Fuente, Valentin Cuervas-Mons. Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation. World Journal of Hepatology 2019; 11(1): 50-64 doi: 10.4254/wjh.v11.i1.50
|
| 19 |
Quirino Lai, Alessandro Vitale, Tommaso Manzia, Francesco Foschi, Giovanni Levi Sandri, Martina Gambato, Fabio Melandro, Francesco Russo, Luca Miele, Luca Viganò, Patrizia Burra, Edoardo Giannini. Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics. Cancers 2019; 11(10): 1568 doi: 10.3390/cancers11101568
|
| 20 |
Mohamed A. Abdallah, Nicha Wongjarupong, Mohamed A. Hassan, Wesam Taha, Abubaker Abdalla, Sally Bampoh, Kristeen Onyirioha, Morgan Nelson, Lyn A. Glubranson, Gregory A. Wiseman, Chad J. Fleming, James C. Andrews, Amit Mahipal, Lewis R. Roberts. The efficacy, safety, and predictors of outcomes of transarterial radioembolization for hepatocellular carcinoma: a retrospective study. Expert Review of Gastroenterology & Hepatology 2020; 14(7): 619 doi: 10.1080/17474124.2020.1777856
|
| 21 |
UEG Week 2019 Poster Presentations. United European Gastroenterology Journal 2019; 7(S8): 189 doi: 10.1177/2050640619854671
|
| 22 |
梓聿 王. Correlation between SII/ALB and the Prognosis of EGFR Gene Mutation in Advanced Non-Small Cell Lung Cancer. Advances in Clinical Medicine 2020; 10(06): 857 doi: 10.12677/ACM.2020.106131
|
| 23 |
Riccardo Pravisani, Federico Mocchegiani, Miriam Isola, Dario Lorenzin, Gian Luigi Adani, Vittorio Cherchi, Elda Righi, Giovanni Terrosu, Marco Vivarelli, Andrea Risaliti, Umberto Baccarani. Controlling Nutritional Status score does not predict patients' overall survival or hepatocellular carcinoma recurrence after deceased donor liver transplantation. Clinical Transplantation 2020; 34(3) doi: 10.1111/ctr.13786
|
| 24 |
Yu-Qing Yang, Zhen-Yu Wen, Xiao-Yan Liu, Zhen-Hu Ma, Yan-E Liu, Xue-Ying Cao, Li Hou, Hui Xie. Current status and prospect of treatments for recurrent hepatocellular carcinoma. World Journal of Hepatology 2023; 15(2): 129-150 doi: 10.4254/wjh.v15.i2.129
|
| 25 |
Weijuan Cao, Xiaomin Yao, Danwei Cen, Yajun Zhi, Ningwei Zhu, Liyong Xu. The prognostic role of platelet-to-lymphocyte ratio on overall survival in gastric cancer: a systematic review and meta-analysis. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-1167-x
|
| 26 |
文燕 章. Molecular Markers and Recurrence of Hepatocellular Carcinoma after Liver Transplantation. Advances in Clinical Medicine 2019; 9(03): 310 doi: 10.12677/ACM.2019.93047
|
| 27 |
Michele Finotti, Alessandro Vitale, Michael Volk, Umberto Cillo. A 2020 update on liver transplant for hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2020; 14(10): 885 doi: 10.1080/17474124.2020.1791704
|
| 28 |
Marcin Nylec, Kamil Derbisz, Patrycja Chrząszcz, Weronika Wrońska, Robert Król, Wojciech Wystrychowski. Preoperative Neutrophil-to-Lymphocyte Ratio as an Independent Predictor of 1-Year Graft Loss and Mortality After Orthotopic Liver Transplantation. Transplantation Proceedings 2020; 52(8): 2472 doi: 10.1016/j.transproceed.2020.03.036
|
| 29 |
Xiaohui Zhi, Kan Jiang, Yue Shen, Xinyu Su, Ke Wang, Yuanyuan Ma, Liqing Zhou. Peripheral blood cell count ratios are predictive biomarkers of clinical response and prognosis for non‐surgical esophageal squamous cell carcinoma patients treated with radiotherapy. Journal of Clinical Laboratory Analysis 2020; 34(10) doi: 10.1002/jcla.23468
|
| 30 |
Nourhan Badwei, Waheed A. Monsef, Iman Montasser, Mohamed Bahaa, Mahmoud El Meteini, Shimaa Y. Kamel. Role of inflammatory markers in predicting hepatocellular carcinoma recurrence after liver transplantation. Egyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00105-8
|
| 31 |
Cem Onal, Ali Murat Sedef, Fatih Kose, Ezgi Oymak, Ozan Cem Guler, Ahmet Taner Sumbul, Sercan Aksoy, Berna Akkus Yildirim, Ali Ayberk Besen, Sadık Muallaoglu, Huseyin Mertsoylu, Gokhan Ozyigit. The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate. Future Oncology 2019; 15(13): 1469 doi: 10.2217/fon-2018-0635
|